"Same office locations as The Center for Allergy and Immunology"

During the past decade, The Center for Rheumatic Disease, Allergy and Immunology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Center for Rheumatic Disease, Allergy and Immunology" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Grifols Therapeutics LLC" with 1 trials as a collaborator, "Saint Luke's Health System" with 1 trials as a collaborator and "St. Luke's Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "The Center for Rheumatic Disease, Allergy and Immunology" are "Systemic Lupus Erythematosus" (2 trials), "Hepatitis C Patients" (1 trials), "IgG Deficiency" (1 trials) and "Infections" (1 trials). Many other conditions were trialed in "The Center for Rheumatic Disease, Allergy and Immunology" in a lesser frequency.

Most popular intervention types in "The Center for Rheumatic Disease, Allergy and Immunology" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "IV Gamunex 10%" (1 trials), "Peripheral lab draws" (1 trials) and "atorvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Center for Rheumatic Disease, Allergy and Immunology" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "The Center for Rheumatic Disease, Allergy and Immunology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in The Center for Rheumatic Disease, Allergy and Immunology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Center for Rheumatic Disease, Allergy and Immunology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".